A clinical-stage and commercializing biopharmaceutical company focused on innovative medicines and diagnostic products for urologic cancers, women's health, and other major diseases
A clinical-stage and commercializing biopharmaceutical company focused on innovative medicines and diagnostic products for urologic cancers, women's health, and other major diseases. Its portfolio includes drug-device combination therapies, oncology drug candidates, and bladder cancer diagnostic products, developed in-house or brought into China through licensing partnerships.